Detalles de la búsqueda
1.
A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Eur J Pharmacol
; 685(1-3): 59-69, 2012 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22542656
2.
[Stimulating glutamatergic neurons as a potential novel therapeutic avenue for schizophrenia].
Nihon Yakurigaku Zasshi
; 136(3): 128-32, 2010 Sep.
Artículo
en Japonés
| MEDLINE | ID: mdl-20838012
Resultados
1 -
2
de 2
1
Próxima >
>>